Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:12 pm Purchase | 2024-12-31 | 13G | ProQR Therapeutics N.V. PRQR | VAN HERK INVESTMENTS B.V. | 11,461,995 10.900% | 3,291,741 (+40.29%) | Filing History |
| 2024-04-26 6:19 pm Purchase | 2024-04-19 | 13G | DermTech, Inc. DMTKQ | VAN HERK INVESTMENTS B.V. | 1,778,057 5.100% | 150,000 (+9.21%) | Filing History |
| 2024-02-14 06:08 am Purchase | 2024-02-09 | 13G | ProQR Therapeutics N.V. PRQR | VAN HERK INVESTMENTS B.V. | 8,170,254 10.100% | 1,024,035 (+14.33%) | Filing History |
| 2024-02-09 06:37 am Purchase | 2023-12-31 | 13G | ProQR Therapeutics N.V. PRQR | VAN HERK INVESTMENTS B.V. | 7,146,219 8.800% | 2,865,354 (+66.93%) | Filing History |
| 2024-02-08 5:18 pm Purchase | 2023-12-31 | 13G | DermTech, Inc. DMTKQ | VAN HERK INVESTMENTS B.V. | 1,628,057 4.800% | 68,126 (+4.37%) | Filing History |
| 2023-09-14 5:20 pm Purchase | 2023-09-11 | 13G | ProQR Therapeutics N.V. PRQR | VAN HERK INVESTMENTS B.V. | 4,280,865 5.300% | 4,280,865 (New Position) | Filing History |
| 2023-06-16 4:27 pm Purchase | 2023-06-07 | 13G | DermTech, Inc. DMTKQ | VAN HERK INVESTMENTS B.V. | 1,559,931 5.000% | 1,559,931 (New Position) | Filing History |
| 2022-03-29 11:21 am Sale | 2022-03-22 | 13G | Marrone Bio Innovations, Inc. MBII | VAN HERK INVESTMENTS B.V. | 8,567,689 4.700% | -535,154 (-5.88%) | Filing History |
| 2022-02-14 12:27 pm Purchase | 2021-12-31 | 13G | Zealand Pharma A/S ZEAL | VAN HERK INVESTMENTS B.V. | 7,321,632 16.800% | 83,208 (+1.15%) | Filing History |
| 2022-02-14 12:25 pm Sale | 2021-12-31 | 13G | Marrone Bio Innovations, Inc. MBII | VAN HERK INVESTMENTS B.V. | 9,102,843 5.100% | -1,213,731 (-11.76%) | Filing History |
| 2021-11-02 4:44 pm Sale | 2021-11-02 | 13D | Galapagos NV GLPG | VAN HERK INVESTMENTS B.V. | 4,635,672 7.100% | -257,563 (-5.26%) | Filing History |
| 2021-01-29 3:14 pm Sale | 2020-12-31 | 13G | Galapagos NV GLPG | VAN HERK INVESTMENTS B.V. | 4,893,235 7.500% | -1,178,237 (-19.41%) | Filing History |
| 2021-01-29 3:14 pm Purchase | 2020-12-31 | 13G | Zealand Pharma A/S ZEAL | VAN HERK INVESTMENTS B.V. | 7,238,424 18.200% | 295,095 (+4.25%) | Filing History |
| 2021-01-29 3:13 pm Sale | 2020-12-31 | 13G | Marrone Bio Innovations, Inc. MBII | VAN HERK INVESTMENTS B.V. | 10,316,574 6.000% | -228,406 (-2.17%) | Filing History |